Table II.
Clinical/laboratory findings | QF positive (n=19) | QF negative (n=22) | Total (n=41) |
---|---|---|---|
Fever ≤14 days | 19 | 22 | 41 |
Chills and rigor | 12 | 14 | 26 |
Myalgia | 13 | 8 | 21 |
Headache | 8 | 8 | 16 |
Cough and expectoration | 5 | 5 | 10 |
Abdominal pain | 8 | 6 | 14 |
Hepatomegaly | 3 | 5 | 8 |
Splenomegaly | 7* | 1 | 8 |
Malaise | 2 | 4 | 6 |
Nausea | 4 | 4 | 8 |
Vomiting | 5 | 9 | 14 |
Pneumonitis | 2 | 2 | 4 |
Lymphadenopathy | - | 1 | 1 |
Endocarditis | - | 1 | 1 |
Leucocytosis (>11,000/µl) | 5 | 3 | 8 |
Low platelet count (≤150,000 millions/ml) | 6 | 5 | 11 |
Increased liver enzymes (AST/ALP/AP) | 4 | 3 | 7 |
RF (n=15) | - | - | - |
CRP (n=18) | 1 | - | 1 |
*P<0.05. AST, aspartate transferase; ALT, alanine transferase; AP, alkaline phosphatase; RF, rheumatoid factor; CRP, C-reactive protein; QF, Q fever